Singapore markets closed

Medicus Sciences Acquisition Corp. (MSAC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
9.78+0.01 (+0.10%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 113.48M
Enterprise value 113.56M
Trailing P/E 54.28
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.33
Enterprise value/revenue N/A
Enterprise value/EBITDA -158.95

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 30.93%
S&P500 52-week change 3-5.66%
52-week high 39.85
52-week low 39.58
50-day moving average 39.80
200-day moving average 39.72

Share statistics

Avg vol (3-month) 338.03k
Avg vol (10-day) 329.05k
Shares outstanding 59.29M
Implied shares outstanding 6N/A
Float 84.57M
% held by insiders 10.00%
% held by institutions 1115.29%
Shares short (28 Apr 2022) 41.08k
Short ratio (28 Apr 2022) 40.1
Short % of float (28 Apr 2022) 40.01%
Short % of shares outstanding (28 Apr 2022) 40.01%
Shares short (prior month 30 Mar 2022) 41.76k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Dec 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-0.82%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)1.9M
Diluted EPS (ttm)0.18
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.43M
Total cash per share (mrq)0.12
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)49.36
Book value per share (mrq)-0.57

Cash flow statement

Operating cash flow (ttm)-798.52k
Levered free cash flow (ttm)-524.38k